Surgical Innovations Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Surgical Innovations Group generated cash of $400,000, which is less than the previous year. Cash used in financing activities reached the amount of -$672,000 last year. Net change in cash is therefore -$987,000.
Cash Flow
| 2014 | -485K | -1.60M | 5.34M |
|---|---|---|---|
| 2015 | 1.50M | -447K | -761K |
| 2016 | 2.84M | -783K | -2.19M |
| 2017 | 1.60M | -8.34M | 7.69M |
| 2018 | 1.65M | -486K | -334K |
| 2019 | 594K | -516K | -1.34M |
| 2020 | 1.04M | -155K | 3.15M |
| 2021 | -433K | -657K | -532K |
| 2022 | 486K | -1.07M | -935K |
| 2023 | 400K | -688K | -672K |
SUN.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.19M | 3.64M | 5.27M | 1.28M | 2.49M | 1.70M | 775K | 976K | 678K | -2.58M |
Operating activities | ||||||||||
Net income | -509K | 264K | -456K | -3.27M | -2.61M | 725K | 626K | 469K | -1.97M | -9.78M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 757K | 587K | 847K | 2.28M | 3.51M | 1.62M | 1.40M | 939K | 927K | 1.34M |
Stock-based compensation expense | 30K | 35K | 30K | 116K | 188K | 120K | -14K | 23K | 0 | 88K |
| Deferred income tax benefit | 30K | 35K | 30K | 116K | 188K | 120K | -14K | 23K | 0 | 88K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 34K | -360K | -412K | 1.07M | 508K | -1.02M | 263K | 178K | 472K | 0 |
Inventories | 308K | -197K | -802K | 758K | -842K | 384K | -238K | 797K | 1.58M | -1.94M |
Accounts payable | -299K | 204K | 276K | -10K | -203K | 48K | -131K | -61K | -538K | 0 |
Cash generated by operating activities | 400K | 486K | -433K | 1.04M | 594K | 1.65M | 1.60M | 2.84M | 1.50M | -485K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -284K | -1.07M | -657K | -155K | -516K | -486K | -775K | -601K | -447K | -1.60M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | -7.13M | -182K | 0 | 0 |
Cash generated by investing activities | -688K | -1.07M | -657K | -155K | -516K | -486K | -8.34M | -783K | -447K | -1.60M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 2.05M | 201K | 0 | 5.30M | 0 | 19K | 2.11M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -353K | -669K | -300K | -150K | -1.3M | -318K | 2.42M | -2M | -780K | 0 |
Cash used in financing activities | -672K | -935K | -532K | 3.15M | -1.34M | -334K | 7.69M | -2.19M | -761K | 5.34M |
Net Change In Cash | -987K | -1.44M | -1.63M | 3.99M | -1.20M | 782K | 934K | -201K | 298K | 3.26M |
Cash at end of period | 1.21M | 2.19M | 3.64M | 5.27M | 1.28M | 2.49M | 1.70M | 775K | 976K | 678K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |